Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

[Experience with simvastatin therapy for the achievement of osteoprotective effects in women with hyperlipidemia].

Semisotova EF, Kochetkova EA, Kiriliuk IN.

Klin Med (Mosk). 2012;90(9):50-3. Russian.

PMID:
23214015
3.

Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.

Chuengsamarn S, Rattanamongkoulgul S, Suwanwalaikorn S, Wattanasirichaigoon S, Kaufman L.

Bone. 2010 Apr;46(4):1011-5. doi: 10.1016/j.bone.2009.12.023.

PMID:
20045497
4.

Acute and long-term effects of corticosteroid therapy on bone metabolism in patients with kidney diseases.

Haris Á, Szabó A, Lányi É, Mucsi I, Polner K.

Clin Nephrol. 2012 Jul;78(1):17-23.

PMID:
22732333
5.

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.

Lange U, Teichmann J, Müller-Ladner U, Strunk J.

Rheumatology (Oxford). 2005 Dec;44(12):1546-8.

PMID:
16263785
6.

Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.

Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L.

J Bone Miner Res. 2004 May;19(5):737-44.

7.

Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.

Chen ZG, Cai HJ, Jin X, Lu JH, Wang J, Fang NY.

Arch Gerontol Geriatr. 2014 Nov-Dec;59(3):515-21. doi: 10.1016/j.archger.2014.07.006.

PMID:
25131773
8.

Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.

Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J.

Clin Endocrinol (Oxf). 1998 May;48(5):561-8.

PMID:
9666867
9.

The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults.

Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG.

Clin Endocrinol (Oxf). 1995 Mar;42(3):249-54.

PMID:
7758229
10.
11.

Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.

Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.

Calcif Tissue Int. 1998 Jan;62(1):40-6.

PMID:
9405732
12.
13.
14.

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.

Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.

J Bone Miner Res. 1994 May;9(5):631-7.

PMID:
8053391
15.

Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study.

Montagnani A, Gonnelli S, Cepollaro C, Pacini S, Campagna MS, Franci MB, Lucani B, Gennari C.

Bone. 2003 Apr;32(4):427-33.

PMID:
12689687
18.

Exposure to CB-153 and p,p'-DDE and bone mineral density and bone metabolism markers in middle-aged and elderly men and women.

Wallin E, Rylander L, Jönssson BA, Lundh T, Isaksson A, Hagmar L.

Osteoporos Int. 2005 Dec;16(12):2085-94.

PMID:
16234998
19.

Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.

Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.

Chin Med J (Engl). 2004 Jul;117(7):1029-35.

PMID:
15265377
20.

Femoral neck osteopenia in patients with inflammatory bowel disease.

Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.

Am J Gastroenterol. 1998 Sep;93(9):1483-90.

PMID:
9732930
Items per page

Supplemental Content

Support Center